Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Impact of dermatological diseases on family members of the patients using Family Dermatology Life Quality Index: A preliminary study in Iran

Handjani Farhad; Kalafi Amir

Volume 16, Issue 4 , 2013, , Pages 128-131

Abstract
  Background: Chronic skin diseases such as vitiligo and psoriasis can impair the quality of life in the patients with these diseases. The impact of chronic and/or severe skin diseases on the lives of family members of the affected patients has only recently been addressed. The tool used for this assessment ...  Read More

2. Detection of Leishmania DNA in paraffin embedded specimens of chronic lupoid leishmaniasis using polymerase chain reaction

Mashayekhi Vahid; Mahmoudi Mahmoud; Rastin Maryam; Tayebi Naser; Taheri Ahmad Reza; Tavakoli Maryam

Volume 15, Issue 3 , 2012, , Pages 69-73

Abstract
  Background: Chronic lupoid leishmaniasis (CLL) is a chronicform of cutaneous leishmaniasis that is usually resistant to antileishmania agents and leishmania is not seen in the histologicsections. We used polymerase chain reaction (PCR) to detectleishmania DNA in CLL specimens.Method: This descriptive ...  Read More

3. Efficacy of topical 5% imiquimod with cryotherapy versus intralesional meglumine antimoniate in the treatment of anthroponotic cutaneous leishmaniasis

Simin Shamsi Meymandi; Manzumeh Shamsi Meymandi; Soodabeh Zandi; Shahriar Dabiri; Mahin Aflatoonian

Volume 14, Issue 2 , 2011, , Pages 42-47

Abstract
  Background: Cutaneous leishmaniasis (CL) is a major world problem. Several types of treatment regimens have been suggested. Imiquimod demonstrated a leishmanicidal activity by increasing local cytokine production. The aim of this study was to determine the efficacy of topical 5% imiquimod with cryotherapy ...  Read More

4. Cutaneous Leishmaniasis in Atopic Dermatitis Patients in Comparison with the Control Group in Kerman

Farajzadeh Saeedeh; Zandi Soodabeh; Vares Behrooz; Sharifzadeh Mahdiyeh; Fekri Ali-Reza

Volume 11, Issue 1 , 2008, , Pages 21-24

Abstract
  Background: Atopic dermatitis is the most common chronic inflammatory dermatitis, due to immunological disorders. Patients with atopic dermatitis are prone to infectious diseases including bacterial infections. On the other hand, atopy may be protective against helminthes parasites. The objective of ...  Read More

5. Comparison of intralesional Glucantime alone with intralesional Glucantime and levamizole in cutaneous leishmaniasis

Rahmat-allah Salmanpour; Mohammad Bahmani

Volume 10, Issue 4 , 2007, , Pages 278-282

Abstract
  Background and aim: Cutaneous leishmaniasis is a common disease in the world and is an endemic disease in Iran. Highly variable results of systemic treatment of cutaneous leishmaniasis with levamisole have been reported in literature so far. The purpose of this study was to evaluate the efficacy and ...  Read More

6. Comparison of 50% trichloroacetic acid and CO2 laser in the treatment of cutaneous leishmaniasis scar

Nilforoushzadeh Afshar Mohammad Ali; Jaffari Fariba; Ansari Nazli; Moradi Shahram

Volume 10, Issue 3 , 2007, , Pages 181-186

Abstract
  Background and aim: The scars of the cutaneous leishmaniasis and psychologic problems of this disease needs different intervention for its correction. Our objective in this study was to compare the efficacy of trichloroacetic acid (TCA) 50 percent solution and CO2 laser for treatment of the atrophic ...  Read More

7. Complete resolution of chronic cutaneous leishmaniasis by combination therapy with systemic Glucantime, oral fluconazole and 50% trichloroacetic acid solution: report of one case

Nilforoushzadeh Mohammad Ali; Haftbaradaran Elaheh; Siadat Amir Hossein

Volume 10, Issue 3 , 2007, , Pages 240-244

Abstract
  Cutaneous leishmaniasis is an endemic disease in Iran and there is no curative treatment. The disfiguring scar that remains after it subsides is a major psychologic and emotional problem in these patients. Chronic leishmaniasis is a rare form of this malady which is seen in 5-7 percent of cases. In this ...  Read More

8. Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic Glucantime

Giti Sadeghian; Masoomeh Sadeghi

Volume 10, Issue 1 , 2007, , Pages 9-12

Abstract
  Background and aim: Antimonial compounds are regarded as the treatment of choice for cutaneous leishmaniasis (CL). Systemic administration of these drugs have some side effects such as cardiotoxicity. The objective of this study was to evaluate the electrocardiographic (ECG) changes in patients with ...  Read More

9. omparative study of oral azithromycin and systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

Layegh Pouran; Panah Mohammad Javad Yazdan; Dadkhah Seyed Masoud; Shakeri Mohammad Taqi; Vosough Elham Mohammadi

Volume 9, Issue 4 , 2006, , Pages 303-307

Abstract
  Background and aim: Complications and resistance to pentavalent antimonial agents in cutaneous leishmaniasis, exhibit the need for effective alternative drugs. The aim of this study was to compare the efficacy of oral azithromycin with systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous ...  Read More

10. Efficacy of combination of topical honey with intralesional injection of Gglucantime in the treatment of acute cutaneous Leishmaniasis

MA Nilforoush Zadeh; Sh Moradi; R Derakhshan; E Haft Baradaran; F Jafari

Volume 9, Issue 3 , 2006, , Pages 221-226

Abstract
  Background and aim: Cutaneous leishmaniasis (CL) is an edemic disease widely spread in Iran. Although several treatments have been tried, none has been found as simple and effective. Honey has been used in the treatment of chronic ulcers and its anti-leishmanial effects have also been reported. So we ...  Read More

11. The efficacy of topical treatment with concentrated boiled extract and Hydroalcoholic extract of cassia fistula in comparison with intralesional injection of Glucantime in the treatment of acute Leishmaniasis

F Jafari; Sh Moradi; MA Nilforoush Zadeh; R Derakhshan; N Ansari

Volume 9, Issue 3 , 2006, , Pages 211-216

Abstract
  Background and aim: Cutaneous leishmaniasis is an endemic disease in Iran. Although there are many different treatments for this disease, there is not any effective treatment yet. Since there has been a number of different reports on the effectiveness of Cassia fistula plant in the treatment of leishmaniasis, ...  Read More

12. Therapeutic effect of direct current electricity on cutaneous Leishmaniasis

M Maleki; Z Javidi; V Mashayekhi; MT Shakeri; Y Nahidi; MA Hamed Shojaei; M Hanifeh Zadeh

Volume 9, Issue 2 , 2006, , Pages 132-138

Abstract
  Background and aim: In spite of the existance of different types of treatment for cutaneous leishmaniasis, an efficient, safe and cheap treatment has not been found yet. There are some studies showing antiparasiticidal effect of direct current electricity both in vivo and in vitro. The objective of this ...  Read More

14. Frequency of resistance to systemically administered Meglumine Antimoniate (Glucantime) in patients with acute cutaneous Leishmaniasis: A cross-sectional study

MA Nilfroush Zadeh; N Anasri; R Derakhshan

Volume 8, Issue 6 , 2006, , Pages 457-461

Abstract
  Background and aim: Pentavalent antimony compounds are the first line treatment for cutaneous leishmaniasis. Clinical resistance to pentavalent antimony in the form of meglumine antimoniate (Glucantime) has been recognized as a problem in leishmaniasis. Herein, clinical response to Glucantime were studied ...  Read More

15. Occurrence of Porokeratosis of Mibelli on an old scar due to cutaneous Leishmaniasis

P Layegh; M Ebrahimi Rad; K Ghafar Zadegan

Volume 8, suppl , 2005, , Pages 5-9

Abstract
  Porokeratosis of Mibelli is a keratinization disorder due to cellular clones that show different degress of dysplasia. Sometimes, these lesions develop on the previously traumatized or burnt skin. Herein, a 24 – year- old female patient is presented with three facial skin lesions on her right cheek ...  Read More

17. A comparison between intralesional hypertonic Sodium Chloride solution and Meglumine Antimoniate (Glucantime) injections in the treatment of cutaneous Leishmaniasis

G Sadeghian; MA Nilforoush Zadeh; M Motevali Emami

Volume 8, Issue 4 , 2005, , Pages 251-255

Abstract
  Background and objective: Different local and systemic modalities are suggested in the treatment of cutaneous leishmaniasis, but the pentavalent antimony compounds are still considered as the first line of treatment. Regarding to increase in clinical drug resistance and adverse effects, efforts to find ...  Read More

18. Comparison of efficacy of oral Fluconazole with intramuscular Glucantime in patients with acute cutaneous Leishmaniasis

SZ Famili; F Pezeshk Poor; V Sepehr; M Vahedian

Volume 8, Issue 2 , 2005, , Pages 97-100

Abstract
  Background: Cutaneous leishmaniasis is an important skin parasitic disease. Ideal treatment is not found yet and seeking for proper drugs continues. Objective: Comparison of the efficacy of fluconazole with systemic glucantime in patients with acute cutaneous leishmaniasis in Ghaem hospital in Mashhad ...  Read More

19. Disseminated cutaneous Leishmaniasis on lymphedema following radiotherapy: A case report

G Sadeghian; F Iraji; MA Nilforoosh Zadeh

Volume 8, suppl , 2004, , Pages 31-34

Abstract
  Cutaneous leishmaniasis (CL) is a parasitic disease, which is hyperendemic in Isfahan, usually caused by L.major and L.tropica. Herein we report a patient with post-mastectomy lymphedema on right upper limb accompanying with the lesions of cutaneous leishmaniasis on the right and left forearms. Following ...  Read More

20. A comparison between the efficacy of intralesional injection of 2% Zinc Sulfate solution with Glucantime in the treatment of acute old world cutaneous Leishmaniasis: A randomized, double-blind, controlled clinical trial

AR Firooz; AR Khatami; A Khamesipour; M Nassiri Kashani; MA Nilforoushzadeh; F Behnia; HR Pazoki Toroudi; Y Dowlati

Volume 7, Issue 4 , 2004, , Pages 209-218

Abstract
  Background: Several treatment modalities have been used for cutaneous leishmaniasis (CL) with various results. In vitro and in vivo studies have shown inhibitory effects of zinc sulfate (ZnSO4) on Leishmania parasites. Objective: To compare the efficacy of intralesional injections of 2% ZnSO4 solution ...  Read More

21. Basal cell carcinoma superimposed on an old scar of localized cutaneous Leishmaniasis: A case report

MH Aziz Jalali; H Ansarin; S Mirzazadeh Javaheri

Volume 7, Issue 3 , 2004, , Pages 192-194

Abstract
  Basal cell carcinoma (BCC) is the most common malignant tumor of the skin, which originates from the basal cell layer of the skin. It is more common in white race with skin types I and II. Some predisposing factors are sunlight, ionizing radiation, arsenic salts, PUVA and scar. We present a case of BCC, ...  Read More

22. Efficacy of integration methods in the control of cutaneous Leishmaniasis in Imamzadeh Agha Ali Abbas in Natanz in Isfahan in 1996-98

MA Nilforoosh Zadeh; T Jalayer; B Ataei; F Jafari; M Motavali Emami

Volume 7, Issue 2 , 2004, , Pages 78-83

Abstract
  Background: Humans, rodents and sandflies have role in transmitted cycle of cutaneous leishmaniasis. To control the disease, promoting the environment, killing the rodent and poisoning the vectors are recommended, individually all over the world. Since, there is no effective vaccine against this disease, ...  Read More

23. Efficacy of Paromomycin ointment prepared in Iran (Paromo-U) against cutaneous Leishmaniasis caused by Leishmania major in mouse model

M Mohebali; P Yaghoobi; B Hooshmand; A Khamesipour

Volume 7, Issue 2 , 2004, , Pages 88-94

Abstract
  Background: Considering the difficulties, adverse effects and unsuitable response to commonly used drugs; it is essential to find an alternative, particularly local treatment for cutaneous leishmaniasis (CL). Objective: Determination of efficacy of topical paromomycin (Paromo-U ointment) against CL caused ...  Read More

24. Efficacy of Permethrin-impregnated clothes in prevention of cutaneous Leishmaniasis: A randomized, double-blind clinical trial

A Asilian; A Sadeghinia; F Shariati; SM Emam Jome; AR Ghoddusi

Volume 6, Issue 2 , 2003, , Pages 25-29

Abstract
  Background: Some researchers claim that permethrin-impregnated clothes are effective in the prevention of cutaneous leishmaniasis. Objectives: To determine the effectiveness of permethrin-impregnated clothes in the prevention of cutaneous leishmaniasis. Patients and Methods: 272 soldiers were randomized ...  Read More

25. Oral Zinc Sulfate in the treatment of acute cutaneous Leishmaniasis

MJ Yazdan Panah; SK Mostoufi; M Soleimani

Volume 6, Issue 2 , 2003, , Pages 20-24

Abstract
  Background: Different local and systemic modalities are suggested in the treatment of cutaneous leishmaniasis (CL), but the pentavalent antimony compounds are still considered as the first line of treatment. Regarding to increase in clinical drug resistance, adverse effects and low compliance of patient, ...  Read More